Trial Profile
Real world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in patients with prior hepatitis-c virus antiviral treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases